Pfizer (PFE) Completes Transaction to Combine Its Upjohn Business with Mylan (MYL) Nov 16, 2020 07:31AM
Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn Oct 30, 2020 01:39PM
Mylan (MYL), Pfizer (PFE) Gain FTC Clearance of Proposed Combination of Mylan and Upjohn Oct 30, 2020 01:24PM
Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn Oct 30, 2020 01:22PM
Mylan (MYL), Pfizer Inc. (PFE) Granted European Commission Approval for Proposed Combination of Mylan and Upjohn Sep 15, 2020 07:05AM
View Older Stories

Sep 15, 2020 07:00AM Mylan and Pfizer Receive European Commission Approval for Proposed Combination of Mylan and Upjohn
Aug 31, 2020 06:00AM Mylan and Biocon Biologics Announce Launch of Semglee™ (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes
Jun 12, 2020 06:21AM Mylan (MYL), Biocon Report FDA Approval of Semglee (insulin glargine injection)
Jun 11, 2020 06:35PM Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection)
Jun 4, 2020 08:03AM Mylan (MYL) and Lupin Receive European Marketing Authorization for Nepexto, Biosimilar Etanercept
Jun 4, 2020 08:00AM Mylan and Lupin Receive European Marketing Authorization for Nepexto®, Biosimilar Etanercept
Mar 27, 2020 09:30AM Mylan and Lupin Announce Positive CHMP Opinion for Nepexto®, Biosimilar Etanercept
Mar 26, 2020 06:46AM Mylan (MYL), Pfizer (PFE) Provide Update Regarding Proposed Combination of Mylan and Upjohn
Mar 26, 2020 06:45AM Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn
Mar 26, 2020 06:45AM Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn
Mar 9, 2020 08:05AM Mylan (MYL) Announces U.S. FDA Accepts BLA Proposed Biosimilar Bevacizumab for Review
Mar 9, 2020 08:00AM U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Bevacizumab for Review
Feb 27, 2020 08:15AM Mylan and Pfizer Announce Appointment of Viatris Chief Financial Officer
Feb 27, 2020 08:15AM Mylan and Pfizer Announce Appointment of Viatris Chief Financial Officer
Feb 27, 2020 08:00AM Mylan and Pfizer Finalize Appointments to Viatris Board of Directors
Feb 27, 2020 08:00AM Mylan and Pfizer Finalize Appointments to Viatris Board of Directors
Dec 18, 2019 08:30AM Pfizer and Mylan Announce Two Future Viatris Board Members
Dec 18, 2019 08:30AM Pfizer and Mylan Announce Two Future Viatris Board Members
Dec 13, 2019 08:05PM Annual Changes to the NASDAQ-100 Index
Dec 2, 2019 07:10AM Mylan (MYL), Biocon Announce Launch of Ogivri (trastuzumab-dkst) in the U.S.
Dec 2, 2019 07:00AM Mylan and Biocon Launch Trastuzumab Biosimilar, Ogivri™ (trastuzumab-dkst), in the U.S.
Nov 12, 2019 12:17PM Mylan (MYL), Pfizer (PFE) Said New Company to Be Named 'Viatris'
Nov 12, 2019 12:15PM Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination
Nov 12, 2019 12:15PM Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination
Jul 29, 2019 06:46AM Mylan (MYL) and Pfizer's (PFE) Upjohn to Combine
Jul 29, 2019 06:45AM Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World’s Need for Medicine
Jul 29, 2019 06:45AM Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World's Need for Medicine
May 15, 2019 05:01PM Mylan and Biocon to Present Final Overall Survival Data for Ogivri™ (trastuzumab-dkst), a biosimilar to Herceptin®, at the American Society of Clinical Oncology (ASCO) Annual Meeting
Mar 7, 2019 03:00PM SBP, Mylan Present Keys to Hurricane Maria Survivor in Welcome Home Party -- Courtesy of $1M Pledge from the Mylan Charitable Foundation
Jan 2, 2019 04:03PM Ironwood and Allergan Announce Settlement with Mylan Resolving LINZESS® (linaclotide) Patent Litigation
Nov 14, 2018 04:09PM Einhorn's Greenlight Capital Enters Michael Kors (KORS), Seadrill (SDRL); Cuts GM (GM), Liquidates Apple (AAPL)
Nov 1, 2018 07:11AM From pharma to prisons, election-sensitive stocks that could swing
Oct 19, 2018 09:31AM Mylan (MYL), Biocon Announce Positive CHMP Opinion for Ogivri, Biosimilar Trastuzumab
Oct 19, 2018 09:30AM Mylan and Biocon Announce Positive CHMP Opinion for Ogivri®, Biosimilar Trastuzumab
Sep 21, 2018 09:31AM Mylan N.V. (MYL) and Biocon Report Positive CHMP Opinion for Fulphila, Biosimilar Pegfilgrastim
Sep 21, 2018 09:30AM Mylan and Biocon Announce Positive CHMP Opinion for Fulphila®, Biosimilar Pegfilgrastim
Aug 14, 2018 07:52AM Einhorn's Greenlight Capital Shows Lowered Stake in Apple (AAPL), GM (GM), Micron (MU) (more....)
Aug 8, 2018 07:46AM S&P 500, Dow edge down as oil prices, trade worries weigh
Jul 17, 2018 08:06AM AbbVie (ABBV) Granted HUMIRA (adalimumab) Patent License with Mylan (MYL)
Jun 28, 2018 12:30AM Lupin and Mylan Partner to Commercialize Enbrel® (Etanercept) Biosimilar
Jun 5, 2018 09:22AM Pre-Open Movers 06/05: (CODX) (GIII) (RGLS) Higher; (ANW) (FRAN) (ASNA) Lower (more...)
Jun 4, 2018 05:36PM After-Hours Stock Movers 06/04: (TWTR) (MYL) (NX) Higher; (ANW) (ASNA) (COOL) Lower (more...)
May 15, 2018 04:09PM Einhorn's Greenlight Capital Enters Office Depot (ODP), Abercrombie & Fitch (ANF) (more...) - 13F
Mar 28, 2018 05:48AM Mylan (MYL) & Biocon Reports Approvals from European Commission and TGA Australia for Semglee, Biosimilar Insulin Glargine
Mar 27, 2018 11:00PM Mylan and Biocon Receive Approvals from the European Commission and TGA Australia for Semglee™, Biosimilar Insulin Glargine
Feb 14, 2018 04:19PM Einhorn's Greenlight Capital Enters Michael Kors (KORS), JP Penney (JCP), Under Armour (more...)
Dec 29, 2017 05:41AM Mylan (MYL) & Biocon Biosimilar Trastuzumab Granted Approval from ANVISA, Brazil Through Partner Libbs
Dec 29, 2017 01:30AM Biocon and Mylan's Biosimilar Trastuzumab Receives Approval from ANVISA, Brazil Through their Partner Libbs
Jun 27, 2017 07:04AM UPDATE: Horizon Pharma (HZNP) Says District Court Upheld VIMOVO Patents
Nov 9, 2016 06:34PM After-Hours Stock Movers 11/09: (SHAK) (OMER) (TASR) Higher; (HLIT) (AVID) (TWTR) Lower (more...)
View Older Stories